Palantir and the NHS – things you need to know (theconversation.com)

Palantir, an American data analytics firm, has been awarded a significant contract to manage the NHS’s £330 million Federated Data Platform, a move that has stirred debate within the AI/ML community. Supporters argue that Palantir's tools can enhance operational efficiency and improve healthcare planning, while critics voice concerns regarding governance, data privacy, and the implications of a private company handling sensitive medical records. The contract, awarded under competitive bidding after Palantir's earlier engagement during the COVID-19 pandemic, highlights ongoing discussions around "vendor lock-in" and the ethical considerations of having a firm with ties to controversial entities oversee public health data. The Federated Data Platform aims to centralize NHS data for improved planning and healthcare services, but questions remain about how data will be protected and used, particularly under the US Cloud Act, which allows American authorities to access data stored by US companies. Critics worry about the trustworthiness of a vendor that has previously partnered with organizations subject to scrutiny for civil liberties violations. While Palantir claims it will act purely as a data processor without commercial interest in NHS data, the ambiguities in contract stipulations and past behaviors foster skepticism among healthcare professionals and advocacy groups, potentially impacting the integrity of the health data ecosystem in the UK.